Introduction
Staphylococcus aureus is a gram-positive bacteria which colonizes the skin and has a preference for the anterior nares, with this colonization's prevalence varying, depending on the population studied. It has a mean of 37.2% in the general population, and a rate of up to 35.5% in the nasal sites of patients with Human
Immunodeficiency Virus (HIV) (1) (2) .
Staphylococcus aureus's resistance to methicillin
(MRSA) was first described in Europe in 1961, as a nosocomial pathogenic agent (3) .
For researching Staphylococcus aureus and, principally, MRSA, the sites of the greatest interest are the nasal mucosa and the skin, due to their characteristic of being naturally colonized.
The colonization of individuals with HIV/AIDS by pathogenic micro-organisms has been associated with higher risk of morbidity and mortality, principally when related to Staphylococcus aureus. Researchers found a rate of 76.7% of colonization with this bacteria in this population, indicating prolonged hospitalization (over 10 days) as a risk factor for resistance to methicillin (4) .
The prevalence of nasal colonization with
Staphylococcus aureus varies depending on the population studied. The recent use of antibiotics and inpatient treatment in the last year have been found as independent predictors for nasal MRSA colonization in HIV-positive patients treated as outpatients (5) . 
In

Method
The present study is quantitative and crosssectional and was undertaken in two units which are The inclusion criteria established were: to be aged over 18 years old; to be aware of the diagnosis of infection with HIV/AIDS; to be clinically well enough to understand the guidance and to take the decision to participate or not. Individuals with HIV/AIDS using any ventilatory equipment which would make consenting or data collection impossible were excluded, as were those who were inpatients before the data collection period.
On the first day of inpatient treatment, (the first www.eerp.usp.br/rlae
Reinato LAF, Pio DPM, Lopes LP, Pereira FMV, Lopes AER, Gir E. or MRSA, by the variables of viral load, CD4+ T cell count, number of episodes of inpatient treatment in the showing that 63.0% of the participants were male and that the mean age was 41 years old (22 to 60 years old).
Discussion
Nasal colonization in individuals with HIV/AIDS was identified more in those who had a low viral load (≤100 copies/ml), CD4+ T lymphocytes count <200 cells/mm 3 , those with a history of at least one episode of inpatient treatment in the previous six months, and who were using antimicrobials. Only MRSA was identified with greater frequency among the individuals who were not using antiretroviral drugs, as, in the MSSA evidence, the majority of the participants were using antiretroviral drugs.
Previous research had identified a rate of 34% of nasal colonization with Staphylococcus aureus in individuals with HIV, emphasizing being a nasal carrier, having a vascular catheter, a low CD4+ T lymphocyte count and neutropenia as important risk factors for infections related to this pathogen (7) .
Research conducted among individuals with HIV found that 83.3% of the nasal carriers of Staphylococcus aureus were patients with CD4 T lymphocytes <200 cells/ mm 3 , while among those who had a CD4 T cell count above 300 cells/mm 3 , MRSA was not isolated (4) .
Inpatient treatment, the previous use of antimicrobials, skin/soft tissue infection or being HIVpositive may all be considered as risk factors for patients who presented colonization with MRSA (8) .
Some risk factors for MRSA infection are indicated for individuals living with HIV, the following being highlighted: the immunosuppressed condition, and associated co-morbidities and specified life-style-related behaviors, such as high-risk sexual practices and the use of illicit drugs (9) .
The use of antimicrobials has also been documented as a risk factor for colonization with Staphylococcus aureus in individuals with HIV (10) .
The professionals identified as colonized (12) .
One study undertaken with health professionals emphasizes the need to implement strategies which cover public policies directed at programs for the control of this pathogen in the hospital setting, promoting broad discussions on this topic (13) .
Conclusion
The concern with identifying colonization with Staphylococcus aureus in the population which lives with HIV/AIDS is growing, in view of the need for interventions for controlling the spread of this pathogen, minimizing correlated future infections.
In spite of being a bacteria first isolated in human beings over four decades ago, Staphylococcus aureus commonly causes the infection of skin and soft tissues, among others, both in people receiving inpatient treatment and those living in the community.
It is necessary for there to be joint action from professionals and government bodies linked to health, so as to improve policies of control related to antimicrobial resistance and to multi-drug-resistant micro-organisms.
